Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Brain health across the entire glycaemic spectrum: the UK Biobank

Victoria Garfield, Aliki-Eleni Farmaki, Sophie V. Eastwood, View ORCID ProfileRohini Mathur, View ORCID ProfileChristopher T. Rentsch, Krishnan Bhaskaran, Liam Smeeth, Nish Chaturvedi
doi: https://doi.org/10.1101/2020.02.18.20024471
Victoria Garfield
1MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, 1-19 Torrington Place, London, United Kingdom, WC1E 7HB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: v.garfield@ucl.ac.uk
Aliki-Eleni Farmaki
1MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, 1-19 Torrington Place, London, United Kingdom, WC1E 7HB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie V. Eastwood
1MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, 1-19 Torrington Place, London, United Kingdom, WC1E 7HB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohini Mathur
2Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom, WC1E 7HT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rohini Mathur
Christopher T. Rentsch
2Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom, WC1E 7HT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher T. Rentsch
Krishnan Bhaskaran
2Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom, WC1E 7HT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam Smeeth
2Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom, WC1E 7HT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nish Chaturvedi
1MRC Unit for Lifelong Health and Ageing at UCL, Institute of Cardiovascular Science, University College London, 1-19 Torrington Place, London, United Kingdom, WC1E 7HB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To understand the relationship across the glycaemic spectrum, with brain health. We hypothesised that individuals with increasingly higher HbA1c would be more likely to have worse brain health outcomes in comparison to normoglycaemic individuals.

Methods UK Biobank participants. HbA1c and diabetes diagnosis define baseline glycaemic categories. Outcomes: incident vascular dementia (VD), Alzheimer’s dementia (AD), hippocampal volume (HV), white matter hyperintensity (WMH) volume, cognitive function and decline. Reference group: normoglycaemic individuals (HbA1c 35-<42 mmol/mol).

Results Pre- and known diabetes increased incident VD, (HR 1.54, 95%CI=1.04;2.28 and 2.97, 95%CI=2.26;3.90). Known diabetes increased AD risk (HR 1.84, 95%CI=1.44;2.36). Pre- and known diabetes elevated risks of cognitive decline (OR 1.42, 1.48;2.96 and 1.39, 1.04;1.75). Pre-diabetes, undiagnosed and known diabetes conferred higher WMH volumes (4%, 26%, 5%,) and lower HV (22.4mm3, 15.2mm3, 62.2mm3). Low-normal HbA1c had 2% lower WMH volume and 13.6mm3 greater HV.

Interpretation Pre and known diabetes increase VD risks; known diabetes increases AD risk. Low-normal HbA1c associates with more favourable neuroimaging outcomes. Our findings may have implications for cardiovascular medication in hyperglycaemia for brain health.

Competing Interest Statement

Author contributions: literature search: VG; study design: VG, NC; data analysis: VG, SVE, A-EF; data interpretation: VG, NC, LS, KB; Writing: VG, NC; commenting on the draft: VG, A-EF, SVE, RM, CTR, KB, LS, NC. KB reports grants from Diabetes UK, grants from British Heart Foundation, during the conduct of the study; grants from Medical Research Council, outside the submitted work. KB holds a Sir Henry Dale Fellowship funded by Wellcome and the Royal Society (grant number 107731/Z/15/Z). LS reports grants from BHF and Diabetes UK, during the conduct of the study; grants from Wellcome, grants from MRC, grants from NIHR, grants from GSK, grants from BHF, outside the submitted work; and is a Trustee of the British Heart Foundation. NC reports grants from Diabetes UK, grants from British Heart Foundation, during the conduct of the study; personal fees from AstraZeneca, grants from Medical Research Council, outside the submitted work. The remaining authors declare that there are no conflicts of interest.

Funding Statement

This work was jointly funded by Diabetes UK and British Heart Foundation grant 15/0005250.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data to support this study are available directly from UK Biobank.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Brain health across the entire glycaemic spectrum: the UK Biobank
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Brain health across the entire glycaemic spectrum: the UK Biobank
Victoria Garfield, Aliki-Eleni Farmaki, Sophie V. Eastwood, Rohini Mathur, Christopher T. Rentsch, Krishnan Bhaskaran, Liam Smeeth, Nish Chaturvedi
medRxiv 2020.02.18.20024471; doi: https://doi.org/10.1101/2020.02.18.20024471
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Brain health across the entire glycaemic spectrum: the UK Biobank
Victoria Garfield, Aliki-Eleni Farmaki, Sophie V. Eastwood, Rohini Mathur, Christopher T. Rentsch, Krishnan Bhaskaran, Liam Smeeth, Nish Chaturvedi
medRxiv 2020.02.18.20024471; doi: https://doi.org/10.1101/2020.02.18.20024471

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)